Author Disclosure Statement
Kala
D.E. received financial support from Alcon, Allergan, AxeroVision, Bausch + Lomb, Hovione, Kala, Novaliq, Novartis, Ocular Therapeutix, and Vistakon. K.K. was an independent contractor at Ora, Inc., throughout the duration of the study. G.O. and M.W. were employees of Ora, Inc., throughout the duration of the study. G.T. received financial support from Mitotech, Kowa, Aldeyra, Topivert, Brim, Palatin, Oyster Point, Allergan, Aerie, Aurinia, ReGenTree, Novaliq, HanAll, and Ora, Inc. P.V. has nothing to disclose. E.B.M. received financial support from Allergan, Aldeyra, Aurinia, HanAll, Mallinckrodt, Mitotech, Nicox, Novaliq, Orasis, Ocular Therapeutix, Palatin, ReGenTree, Santen, and Topivert. J.W., J.D., R.J., S.T.W., and C.S. are employees of Palatin Technologies, Inc.